REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

REGENXBIO Inc. (Nasdaq: RGNX) announced its participation in two upcoming virtual investor conferences in June 2021. The Bank of America 2021 Napa Biopharma Virtual Conference will feature a fireside chat on June 16, 2021, at 12:30 p.m. E.T. Additionally, the Raymond James Human Health Innovation Conference is scheduled for June 21, 2021. Investors can access the live webcast of the Bank of America event on REGENXBIO's website, with an archived replay available for 30 days thereafter. REGENXBIO focuses on gene therapy through its proprietary NAV Technology Platform.

ROCKVILLE, Md., June 9, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following June investor conferences, which will each be held in a virtual meeting format:

Bank of America 2021 Napa Biopharma Virtual Conference
Fireside Chat: Wednesday, June 16, 2021 at 12:30 p.m. E.T.

Raymond James Human Health Innovation Conference
Date: Monday, June 21, 2021

A live webcast of the Bank of America fireside chat can be accessed in the 'Investors' section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available on the same website for approximately 30 days following the fireside chat.

About REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV^® Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.

Contacts:

Tricia Truehart
Investor Relations and Corporate Communications
347-926-7709
ttruehart@regenxbio.com

Investors:
Brendan Burns, 212-600-1902
brendan@argotpartners.com

Media:
David Rosen, 212-600-1902
david.rosen@argotpartners.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-301308489.html

SOURCE REGENXBIO Inc.

FAQ

When is REGENXBIO participating in the Bank of America 2021 Napa Biopharma Virtual Conference?

REGENXBIO will participate in the Bank of America 2021 Napa Biopharma Virtual Conference on June 16, 2021, at 12:30 p.m. E.T.

What other conference is REGENXBIO attending in June 2021?

In addition to the Bank of America conference, REGENXBIO will attend the Raymond James Human Health Innovation Conference on June 21, 2021.

How can investors access the REGENXBIO Bank of America conference webcast?

Investors can access the live webcast of the Bank of America fireside chat on REGENXBIO's website in the 'Investors' section.

What is the NAV Technology Platform of REGENXBIO?

The NAV Technology Platform is REGENXBIO's proprietary adeno-associated virus (AAV) gene delivery platform used in various therapeutic areas.

How long will the webcast replay from the Bank of America event be available?

The archived replay of the webcast will be available on REGENXBIO's website for approximately 30 days following the event.